Clinical Trial Update: StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating StrataGraft overlay of meshed autograft for full-thickness burns was terminated, with results posted in May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Full-thickness Burn

Drugs mentioned

• StrataGraft Overlay of Meshed Autograft

Snippet

Sponsor: Stratatech, a Mallinckrodt Company | Conditions: Full Thickness Thermal Burn | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-05-16